🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for revolutionary discoveries that illuminate how the immune system targets harmful pathogens while protecting the healthy tissues.

Three esteemed scientists—from Japan Prof. Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this honor.

Their work uncovered specialized "sentinels" within the defense system that eliminate rogue defense cells that could harming the body.

These findings are now paving the way for new therapies for immune disorders and malignancies.

These laureates will share a prize fund valued at 11m Swedish kronor.

Crucial Findings

"The research has been decisive for comprehending how the immune system operates and the reason we don't all develop severe autoimmune diseases," commented the head of the Nobel Committee.

This trio's research explain a core question: How does the immune system protect us from countless invaders while keeping our own tissues unharmed?

Our body's protection system employs white blood cells that search for signs of disease, including pathogens and germs it has never encountered.

These defenders utilize detectors—called recognition units—that are produced by chance in countless variations.

This provides the defense network the capacity to fight a broad range of invaders, but the randomness of the mechanism inevitably creates immune cells that may target the body.

Protectors of the Immune System

Scientists previously understood that some of these harmful white blood cells were eliminated in the thymus—where white blood cells develop.

The latest award honors the discovery of regulatory T-cells—known as the immune system's "security guards"—which patrol the body to disarm other defenders that attack the body's own tissues.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.

A prize committee stated, "The discoveries have laid the foundation for a novel area of research and spurred the development of new treatments, for instance for cancer and immune disorders."

In malignancies, regulatory T-cells block the body from attacking the tumor, so studies are aimed at reducing their quantity.

For self-attack disorders, experiments are testing boosting regulatory T-cells so the body is not under attack. A comparable approach could also be useful in minimizing the risks of organ transplant failure.

Pioneering Studies

Prof Shimon Sakaguchi, of a Japanese institution, performed tests on mice that had their thymus removed, causing autoimmune disease.

The researcher showed that injecting immune cells from healthy animals could stop the disease—implying there was a system for preventing defenders from attacking the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an inherited autoimmune disease in rodents and humans that led to the identification of a genetic factor vital for the way T-regs operate.

"The groundbreaking work has revealed how the body's defenses is kept in check by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a leading physiology specialist.

"This work is a remarkable illustration of how fundamental physiological research can have far-reaching implications for public health."